LBF20309HO01: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 6: | Line 6: | ||
|LipidBank=DFA8109 | |LipidBank=DFA8109 | ||
|LipidMaps=LMFA03050010 | |LipidMaps=LMFA03050010 | ||
|SysName= dl-14,15-Dihydroxy- (5-cis | |SysName=dl-14,15-Dihydroxy- (cis-5,cis-8,cis-11) -eicosatrienoic acid | ||
|Common Name=&&(+-) -14,15-Dihydroxy-5Z,8Z,11Z-eicosatrienoic acid&&dl-14,15-Dihydroxy- (5Z,8Z,11Z) -eicosatrienoic acid&& | |Common Name=&&(+-) -14,15-Dihydroxy-5Z,8Z,11Z-eicosatrienoic acid&&dl-14,15-Dihydroxy- (5Z,8Z,11Z) -eicosatrienoic acid&& | ||
|Source= | |Source= | ||
Latest revision as of 16:21, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | DFA8109 |
| LipidMaps | LMFA03050010 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20309HO01 |
| (+-) -14,15-Dihydroxy-5Z,8Z,11Z-eicosatrienoic acid | |
|---|---|
| |
| Structural Information | |
| dl-14,15-Dihydroxy- (cis-5,cis-8,cis-11) -eicosatrienoic acid | |
| |
| (+-)14,15-DiHETrE | |
| Formula | C20H34O4 |
| Exact Mass | 338.24570957599997 |
| Average Mass | 338.48156 |
| SMILES | C(CCC(O)C(O)CC=CCC=CCC=CCCCC(O)=O)CC |
| Physicochemical Information | |
| Epoxide hydrolases convert the EpETrEs into vicinal diols Oliw_EH et al., with the concurrent loss of much of their biological activity. (±)14,15-DiHETrE is the urinary metabolite of (±)14(15)-EpETrE which has been documented by GC/MS to be elevated in pregnancy induced hypertension Catella_F et al.. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
